Oat & Iil India Laboratories Profile
Key Indicators
- Authorised Capital ₹ 39.75 Cr
as on 29-07-2024
- Paid Up Capital ₹ 39.75 Cr
as on 29-07-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 0.18%
(FY 2023)
- Profit -42.99%
(FY 2023)
- Ebitda -21.64%
(FY 2023)
- Net Worth 2.54%
(FY 2023)
- Total Assets 5.85%
(FY 2023)
About Oat & Iil India Laboratories
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 39.75 Cr and a paid-up capital of Rs 39.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Oat & Iil India Laboratories Private Limited India are Naveen Pant as Company Secretary, Satoshi Fukunaga as Cfo, and Yukiteru Otani as Ceo. Yukiteru Otani, Hisashi Oka, and Rajesh Aggarwal serve as directors at the Company.
- CIN/LLPIN
U73100DL2013FTC249117
- Company No.
249117
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
06 Mar 2013
- Date of AGM
13 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oat & Iil India Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Pant | Company Secretary | 22-Jan-2018 | Current |
| Satoshi Fukunaga | CFO | 26-Jul-2022 | Current |
| Yukiteru Otani | CEO | 15-Jun-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Aggarwal  | Director | 06-Mar-2013 | Current |
Hisashi Oka  | Director | 24-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Oat & Iil India Laboratories.
Oat & Iil India Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.18% increase. The company also saw a substantial fall in profitability, with a 42.99% decrease in profit. The company's net worth moved up by a moderate rise of 2.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oat & Iil India Laboratories?
In 2023, Oat & Iil India Laboratories had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oat & Iil India Laboratories?
Oat & Iil India Laboratories has a workforce of 59 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oat & Iil India Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oat & Iil India Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
